The WHO released new guidance on GLP-1 medications for adults with obesity, recommending their long-term, continuous use when ...

A range of blockbuster weight-loss and diabetes drugs could help shift the trajectory of the global obesity epidemic, which ...

A range of blockbuster weight-loss and diabetes drugs could help shift the trajectory of the global obesity epidemic, which ...

The World Health Organization (WHO) has finally made its recommendations on using glucagon-like peptide-1 (GLP-1) ...

Obesity remains a pressing global health challenge and was linked to 3.7 million deaths in 2024. - Kenya breaking news | Kenya news today | Capitalfm.co.ke ...

ABC News’ medical contributor Dr. Alok Patel explains the World Health Organization’s newest guidelines that say GLP-1 ...

There are more than 123 million people in the U.S. living with obesity, and this prevalence is largely due to a lack of access to care, environmental factors, stigma and inadequate coverage, according ...

WHO has issued its first global guideline supporting the use of GLP-1 weight-loss medicines for long-term obesity care, ...

An enemy of brown fat is the AC3-AT protein—found within the fat itself—which can shut down brown fat’s activation and cancel ...

Thomas W. Spoehr, a retired Army lieutenant general, is director of the Center for National Defense at The Heritage Foundation. Isaac Tang is a member of the Young Leaders Program at The Heritage ...

A range of weight-loss and diabetes drugs could help shift the trajectory of the global obesity epidemic, which affects over ...